Sunday, November 22nd, 2009

Posts Tagged ‘ OREX ’

Investing in the Biotech Sector: 5 Elements To Consider

Mar 31st, 2009 | By Marc Lichtenfeld | Category: Featured

When Arena Pharmaceuticals (Nasdaq: ARNA) released positive Phase III data on its obesity drug, Lorcaserin, many people expected shares to take off. After all, the company’s press release on Monday confirmed that the drug had proven to be safe and effective.